Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients With Sickle Cell Disease

NCT05561140 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT05561140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05561140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients With Sickle Cell Disease
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Terminated
Start date
May 30, 2022
Completion date
October 22, 2024
Enrollment
88 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

leg ulcers, sickle cell disease